Formulation and Characterization of Silibinin Entrapped Nano-Liquid Crystals for Activity against Aβ 1-42 Neurotoxicity in In-Vivo Model.
Autor: | Singh A; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Raebareli, Lucknow, Uttar Pradesh, 226002, India., Rakshit D; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) - Guwahati, Changsari, Kamrup, Assam-781101, India., Kumar A; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) - Guwahati, Changsari, Kamrup, Assam-781101, India., Mishra A; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) - Guwahati, Changsari, Kamrup, Assam-781101, India., Shukla R; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Raebareli, Lucknow, Uttar Pradesh, 226002, India. rahul.shukla@niperraebareli.edu.in. |
---|---|
Jazyk: | angličtina |
Zdroj: | AAPS PharmSciTech [AAPS PharmSciTech] 2024 Jul 01; Vol. 25 (6), pp. 149. Date of Electronic Publication: 2024 Jul 01. |
DOI: | 10.1208/s12249-024-02859-x |
Abstrakt: | Silibinin (SIL) Encapsulated Nanoliquid Crystalline (SIL-NLCs) particles were prepared to study neuroprotective effect against amyloid beta (Aβ (© 2024. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.) |
Databáze: | MEDLINE |
Externí odkaz: |